AIM ImmunoTech (AIM) Short-term Investments (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Short-term Investments came in at $63000.0 in Q1 2026, down 95.33% YoY from $1.3 million in Q1 2025, and up 1.61% on a QoQ basis from $62000.0 in Q4 2025.
AIM ImmunoTech (AIM) Short-term Investments (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Short-term Investments data on file, last reported at $63000.0 in Q1 2026.
- Quarterly Short-term Investments fell 95.33% year-over-year to $63000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63000.0 (down 95.33% YoY) and the FY2025 annual result came in at $62000.0, down 99.25% from the prior year.
- Short-term Investments climbed to $63000.0 in Q1 2026, from $62000.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $8.2 million in Q4 2024 to a low of $62000.0 in Q3 2025.
- A 5-year average of $5.1 million and a median of $7.1 million in 2022 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments advanced 8.03% — and 2025, when it tumbled 99.25%.
- Tracing AIM's Short-term Investments over 5 years: stood at $7.1 million in 2022, then grew by 6.92% to $7.6 million in 2023, then gained by 8.03% to $8.2 million in 2024, then plunged by 99.25% to $62000.0 in 2025, then rose by 1.61% to $63000.0 in 2026.
- The last three Short-term Investments figures came in at $63000.0 (Q1 2026), $62000.0 (Q4 2025), and $62000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 359,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Sep 30, 2024 | 6.29 Mn |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 7.65 Mn |
| Dec 31, 2023 | 7.63 Mn |
| Sep 30, 2023 | 7.17 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Dec 31, 2021 | 16.18 Mn |
| Sep 30, 2021 | 16.51 Mn |
| Mar 31, 2021 | 1.16 Mn |